Skip to main content

Articles

Obinutuzumab Prolongs Survival in Follicular Lymphoma

Letters to the Editor

Misunderstanding of Findings Related to a Recent Article

Cost, Access, and Delivery Challenge New Oncology Drug Options

Value-Based Oncology Management and Outcomes-Based Contracting

Cost-Savings Measures Will Dot the Oncology Landscape

ASCO CEO Addresses Quest for Value in Cancer Care

Quality Measures Are Key to Supporting Drug Value

Cancer Treatment Costs and Trends Beckon Risk-Sharing Future

PhRMA’s Perspective on Value-Driven Healthcare

FDA News - December 2016

Page 98 of 244
Results 971 - 980 of 2436